Results 121 to 130 of about 87,373,768 (197)

Scoping review of policies and practices toward medications with opioids use disorder in problem-solving courts

A review of policies and practices toward medications for opioid use disorder (MOUD), including utilization of MOUD, in problem-solving courts in the US since ...
Barbara Andraka-Christou
core  

Health Plan Disenrollment and Mortality After Initiation of Medications for Opioid Use Disorder. [PDF]

JAMA Psychiatry
Nguyen AP, Binswanger IA, Narwaney KJ, Goodrich G, Christine PJ, Campbell CI, Xu S, Loree AM, Glanz JM.   +8 more
europepmc   +1 more source

Development and Testing of a Peer Recovery Support Services Intervention for Retention on Medications for Opioid Use Disorder. [PDF]

J Addict Med
Wenzel KR, Carrano J, Bormel A, Olaiya O, Pattanaik S, Fishman M.   +5 more
europepmc   +1 more source

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

, 2018
Kyle C Molina, Kathleen A Fairman, David A Sclar Department of Pharmacy Practice, Midwestern University College of Pharmacy–Glendale, Glendale, AZ, USA Background: Opioids are not recommended for routine treatment of migraine because their benefits
Sclar DA, Molina KC, Fairman KA
core  

Opioid use disorder deaths and the effects of medication therapy [PDF]

The American Journal of Drug and Alcohol Abuse, 2019
Mannelli, Paolo, Wu, Li-Tzy
openaire   +2 more sources

A lifeline on wheels: perspectives of stakeholders on the implementation and impact of a mobile medications for opioid use disorder unit. [PDF]

Addict Sci Clin Pract
Kang A, Bailey A, Hurley L, Martin R.
europepmc   +1 more source

Yoga MAT: A factorial randomized study using the Multiphase Optimization Strategy to develop a multicomponent yoga intervention for people with chronic pain taking medications for opioid use disorder. [PDF]

Drug Alcohol Depend
Uebelacker L, Saper RB, Roseen EJ, Taylor LE, Abrantes AM, Anderson B, Sprecht-Walsch S, Lorin L, Ikai D, Desaulniers J, Braun TD, Baldwin M, D'Afflitti J, Hurstak E, Bales R, Min J, O'Keeffe B, Guastaferro K, Strayhorn J, Stein MD.   +19 more
europepmc   +1 more source

Global perspectives on telemedicine-enabled medications for opioid use disorder: Practices, priorities, and barriers. [PDF]

J Telemed Telecare
Schofield J, Baldacchino AM, Ambekar A, Anaba H, Butner JL, Day N, Ekhtiari H, Elomari F, Ferri M, Kokkolis K, Kouimtsidis C, Levola J, Long J, Martell D, Parker DG, Rahimi-Movaghar A, Siste K, Steiger S, Zonoozi AK, Tay Wee Teck J.   +19 more
europepmc   +1 more source

Medication Treatment for Opioid Use Disorders:

Delaware Journal of Public Health, 2017
openaire   +3 more sources

The Association Between Receiving Medications for Opioid Use Disorder and Human Immunodeficiency Virus Testing: Findings From the Rural Opioid Initiative. [PDF]

J Addict Med
Zinsli KA, Mixson LS, Delaney JA, Feinberg J, Stopka TJ, Seal DW, Smith GS, Pho MT, Wu EL, Jenkins W, Cooper HLF, Young AM, Khoury D, Friedmann PD, Miller WC, Go VF, Korthuis PT, Spencer H, Westergaard RP, Tsui JI.   +19 more
europepmc   +1 more source